Noseguard for Prevention of Respiratory Infections in Real-World Use

This study is a prospective clinical study to evaluate the effectiveness of combined use of two nasal protective medical devices (Noseguard and Noseguard Night) in reducing respiratory infection rates, including COVID-19 and influenza, in real-world conditions. The study will also assess usability, satisfaction, and safety using electronic patient-reported outcomes (ePRO).

NCT Number	NCT07516977
Lead Sponsor	Daewoong Pharmaceutical Co. LTD.
Conditions	Respiratory Infection Virus, COVID-19, Influenza
Enrollment	2,000 participants
Start Date	2026-04-20
Primary Completion	2026-08-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-08